Revenue Projections - The company expects to achieve an annual revenue of RMB 580 million to RMB 640 million in 2025, representing an increase of RMB 74.26 million to RMB 134.26 million, or a year-on-year growth of 14.68% to 26.55%[3]. - The company achieved a revenue of RMB 505.74 million in 2024, with a net loss of RMB 35.24 million attributable to the parent company[7]. Profit Projections - The projected net profit attributable to the parent company for 2025 is expected to be between RMB 28 million and RMB 40 million, an increase of RMB 63.24 million to RMB 75.24 million compared to the previous year, marking a turnaround from loss to profit[3]. - The net profit attributable to the parent company, excluding non-recurring gains and losses, is expected to be between RMB 23 million and RMB 34 million, an increase of RMB 58.09 million to RMB 69.09 million year-on-year, also indicating a turnaround from loss to profit[3]. - The improvement in net profit is primarily due to increased overall sales and enhanced gross profit margins, driven by a higher sales proportion of high-margin new products and effective cost reduction measures[9]. Product Development and Market Performance - The significant increase in revenue is attributed to the successful R&D and market promotion of new products, particularly in the pressure product line and inertial sensors, which saw substantial growth compared to the previous year[8]. Performance Forecast and Audit - The company emphasizes that the performance forecast is based on preliminary calculations and has not been audited by certified public accountants[10]. - The company assures that there are no significant uncertainties affecting the accuracy of this performance forecast[10]. - Investors are advised that the forecast data is preliminary and the final audited financial data will be disclosed in the official 2025 annual report[11]. - The performance forecast period is from January 1, 2025, to December 31, 2025[4].

Financial Performance Forecast - The company expects a net profit attributable to shareholders of 52 million to 71 million yuan for 2025, a decrease of 56.29 million to 75.29 million yuan compared to the previous year, representing a decline of 44.22% to 59.15%[4] - The projected net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between -66 million and -85 million yuan, a decrease of 152.41 million to 171.41 million yuan year-on-year, indicating a decline of 176.38% to 198.37%[4] - In 2024, the company reported a total profit of 141.68 million yuan and a net profit attributable to shareholders of 127.29 million yuan[6] - The basic earnings per share for 2024 were 0.40 yuan[6] Factors Affecting Profitability - The decrease in profit is primarily due to new projects from subsidiaries not yet reaching scale production, leading to increased fixed costs and depreciation[7] - The company faces intensified market competition, resulting in a downward trend in product processing fees, which negatively impacts profits[7] - Increased R&D investment for long-term development has led to higher short-term expenses, affecting profitability[7] Earnings Forecast and Risks - The earnings forecast is preliminary and has not been audited by a registered accountant[8] - The company assures that there are no significant uncertainties affecting the accuracy of the earnings forecast[8] - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change in the official 2025 annual report[9]

证券代码：688203 证券简称：海正生材 公告编号：2026-02 浙江海正生物材料股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 （1）经财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的净 利润为 750 万元到 950 万元，与上年同期相比，将减少 2,600.46 万元到 2,800.46 万元，同比减少 73.24%到 78.88%。 （2）归属于母公司所有者的扣除非经常性损益的净利润为 550 万元到 750 万元，与上年同期相比，将减少 2,372.89 万元到 2,572.89 万元，同比减少 75.98% 到 82.39%。 （三）本次业绩预告未经注册会计师审计。 二、上年同期业绩情况和财务状况 四、风险提示 截至本公告披露日，公司未发现影响本次业绩预告内容准确性的重大不确定 因素。 五、其他说明事项 本公告所载预计财务数 ...

证券代码：600794 证券简称：保税科技 编号：临 2026-001 张家港保税科技（集团）股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本期业绩预告适用于《上海证券交易所上市公司自律监管指南第 1 号— —公告格式》第二十八号 1.上市公司业绩预告适用情形之"（一）净利润为负 值"。 张家港保税科技（集团）股份有限公司（以下简称"公司"）参股企业 洋山申港国际石油储运有限公司（以下简称"洋山申港"）因不可抗力导致持续 经营能力存有不确定性，故公司 2025 年度长期股权投资计提相应减值准备，导 致公司 2025 年年度实现归属于母公司所有者的净利润预计为-14,000 万元至 -8,000 万元，公司 2025 年年度实现归属于母公司所有者的扣除非经常性损益后 的净利润为-23,000 万元至-17,000 万元。剔除前述因素影响后，公司预计 2025 年年度实现归属于母公司所有者的净利润为 14,000 万元，预计 2025 年年度实现 归属于母公司所有者的扣除非 ...

证券代码：300730 证券简称：科创信息 公告编号：2026-001 湖南科创信息技术股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为负值 特此公告。 湖南科创信息技术股份有限公司 以区间数进行业绩预告的 单位：万元 | 项 | 目 | 本报告期 | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | -16,000 | ～ | -12,000 | -6,382 | | 扣除非经常性损 益后的净利润 | | -16,200 | ～ | -12,200 | -6,493 | 二、与会计师事务所沟通情况 本次业绩预告相关财务数据是公司财务部门初步测算的结果，未经会计师事务所审计。 公司已就本次业绩预告有关事项与会计师事务所进行了预沟通，与会计师事务所在本次业 绩预告方面不存在重大分歧。 三、业绩变动原因 ...

Financial Performance Forecast - The company expects a net loss attributable to shareholders of between -52 million and -42 million yuan for the year 2025, a decrease of 73.29 million to 63.29 million yuan compared to the previous year, representing a year-on-year decline of 344.23% to 297.26%[3] - The anticipated net profit attributable to shareholders, after deducting non-recurring gains and losses, is projected to be between -72 million and -62 million yuan, a decrease of 86.25 million to 76.25 million yuan compared to the previous year, reflecting a year-on-year decline of 605.13% to 534.97%[3] - The company's total profit for the previous year was 9.4344 million yuan, with a net profit attributable to shareholders of 21.2913 million yuan, and a net profit after deducting non-recurring gains and losses of 14.2538 million yuan[5] Revenue and Profitability Challenges - The decline in revenue is primarily due to the implementation of national centralized procurement policies, which significantly reduced the selling price of the company's HPV product line, leading to a revenue decrease of approximately 46.5 million yuan[8] - The gross profit margin for the HPV product line also faced pressure, with a year-on-year decrease of approximately 46 million yuan[8] Business Strategy and Investment - The company is actively optimizing its business structure by focusing on core business revenue expansion and reducing the scale of agency product business[8] - To enhance long-term competitive advantage, the company is increasing its investment in product research and development, particularly in the fields of pathological intelligence and tumor companion diagnostics, despite a rise in operating costs[8] Non-Operating Income and Audit Information - Non-operating gains and losses have increased due to higher investment income from associated companies[9] - The financial data provided in the performance forecast has not been audited by a registered accountant and is subject to final audit results[10] - Investors are advised to pay attention to investment risks as the forecast data is preliminary and the accurate financial data will be disclosed in the audited annual report for 2025[12]

Financial Performance - The company expects a net loss attributable to shareholders of between -140 million and -115 million yuan for the fiscal year 2025, compared to a net profit of 140.04 million yuan in the same period last year[3]. - The projected net profit attributable to shareholders after deducting non-recurring gains and losses for 2025 is estimated to be between -160 million and -135 million yuan, down from 121.24 million yuan in the previous year[3]. - The total profit for the previous year was 172.91 million yuan, with a net profit attributable to shareholders of 140.04 million yuan[4]. Market Challenges - The decline in performance is primarily due to a significant drop in household photovoltaic installations in the European market, affecting sales and gross profit of micro-inverters[7]. R&D and Innovation - The company has increased its R&D investment, leading to a rapid growth in R&D expenses as it continues to innovate and enhance its integrated solar storage product matrix[7]. Market Expansion - The company is actively expanding its overseas market presence, particularly in emerging markets in Asia, Africa, and Latin America, resulting in increased sales expenses[7]. Earnings Forecast - The earnings forecast has not been audited by registered accountants, and the company has not identified any major uncertainties affecting the accuracy of this forecast[8]. - Investors are advised to note that the forecast data is preliminary and the final audited financial data will be disclosed in the official 2025 annual report[9].

证券代码：688060 证券简称：云涌科技 公告编号：2026-002 江苏云涌电子科技股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 报告期内，公司归属于母公司所有者的净利润、归属于母公司所有者的 扣除非经常性损益的净利润较上年同期亏损大幅收窄，主要得益于： （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况 1、经财务部门初步测算，江苏云涌电子科技股份有限公司（以下简称 "公司"）预计 2025 年度实现归属于母公司所有者的净利润-1,470 万元到- 980 万元，与上年同期（法定披露数据）相比，亏损将减少 2,039.31 万元到 2,529.31 万元，同比亏损收窄 58.11%到 72.07%。 2、预计 2025 年度实现归属于母公司所有者的扣除非经常性损益后的净 利润-1,755.00 万元到-1,170.00 万元，与上年同期（法定披露数据）相 比，亏损将减少 2,090.60 万元到 2, ...

股票代码：000762 股票简称：西藏矿业 编号：临2026-001 西藏矿业发展股份有限公司 2025 年年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、本期业绩预计情况 1.业绩预告期间:2025 年 1 月 1 日至 2025 年 12 月 31 日 | 项 目 | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | 亏损：2,000.00 万元至 | 4,000.00 | 万元 | 盈利：11,174.38 | 万元 | | | 比上年同期下降：117.90%至 | | 135.80% | | | | 扣除非经常性损益 后的净利润 | 亏损：3,000.00 万元至 | 6,000.00 | 万元 | 盈利：7,635.20 | 万元 | | | 比上年同期下降：139.29%至 | | 178.58% | | | | 基本每股收益 | 亏损：0.038 元/股至 | 0.077 元/股 | | 盈利：0.21 元/股 | | | 营 ...

一、本期业绩预告情况 （一）业绩预告期间 证券代码：688570 证券简称：天玛智控 公告编号：2026-003 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 北京天玛智控科技股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （二）每股收益：0.78元。 三、本期业绩变化的主要原因 报告期内，受煤炭行业周期性调整及能源结构加速转型影响，公司主要客户 投资决策趋于审慎，资本开支收紧，公司产品市场总需求降低。同时，行业竞争 进一步加剧，公司主动调整价格策略，以具备竞争力的产品定价巩固市场份额， 导致公司收入规模收缩，主营业务产品毛利率下降。在上述因素影响下，公司的 净利润有所下滑。 四、风险提示 本次业绩预告是公司财务部门基于自身专业判断进行的初步核算，未经注册 1 1.经财务部门初步测算，预计2025年年度实现归属于母公司所有者的净利润 为8,400.00万元到11,340.00万元，与上年同期（法定披露数据）相比，将减少 22,617.51万元 ...